174 related articles for article (PubMed ID: 30734047)
1. Topical Steroid Withdrawal: A Case Series of 10 Children.
Sheary B
Acta Derm Venereol; 2019 May; 99(6):551-556. PubMed ID: 30734047
[TBL] [Abstract][Full Text] [Related]
2. A Qualitative Study Exploring the Views and Experiences of Adults Who Decided to Cease Long-term Topical Steroid Use.
Sheary B; Tyson C; Harris MF
Dermatitis; 2021 Nov-Dec 01; 32(6):e131-e133. PubMed ID: 33654020
[No Abstract] [Full Text] [Related]
3. A systematic review of topical corticosteroid withdrawal ("steroid addiction") in patients with atopic dermatitis and other dermatoses.
Hajar T; Leshem YA; Hanifin JM; Nedorost ST; Lio PA; Paller AS; Block J; Simpson EL;
J Am Acad Dermatol; 2015 Mar; 72(3):541-549.e2. PubMed ID: 25592622
[TBL] [Abstract][Full Text] [Related]
4. Steroid Withdrawal Effects Following Long-term Topical Corticosteroid Use.
Sheary B
Dermatitis; 2018; 29(4):213-218. PubMed ID: 29923852
[TBL] [Abstract][Full Text] [Related]
5. Erythema, pruritus, and diffuse peeling of skin during dupilumab therapy for atopic dermatitis in three adults.
Al Hammadi A; Parmar NV
Int J Dermatol; 2019 Jan; 58(1):e14-e15. PubMed ID: 30390308
[No Abstract] [Full Text] [Related]
6. Difficulties in treating steroid withdrawal: intermittent ACTH and low dose systemic cyclosporin used to treat a senile erythroderma patient.
Horiuchi Y
J Dermatol; 2000 Jan; 27(1):44-8. PubMed ID: 10692825
[TBL] [Abstract][Full Text] [Related]
7. Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis.
Prescrire Int; 2004 Dec; 13(74):209-12. PubMed ID: 15599989
[TBL] [Abstract][Full Text] [Related]
8. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
[TBL] [Abstract][Full Text] [Related]
9. [Safety of topical tacrolimus and pimecrolimus in children with atopic dermatitis].
Rodríguez Orozco AR; Ruiz Reyes H; Marín Hernández D
Rev Alerg Mex; 2005; 52(4):171-6. PubMed ID: 16268186
[TBL] [Abstract][Full Text] [Related]
10. Topical corticosteroids for skin disorders in infants and children.
Harper J
Drugs; 1988; 36 Suppl 5():34-7. PubMed ID: 2978289
[TBL] [Abstract][Full Text] [Related]
11. Kaposi's varicelliform eruptions during the course of steroid withdrawal in a senile erythroderma patient: cure of regional erythrodermic lesions following infection.
Horiuchi Y
J Dermatol; 1999 Jun; 26(6):375-8. PubMed ID: 10405484
[TBL] [Abstract][Full Text] [Related]
12. Cataract and retinal detachment in patients with severe atopic dermatitis who were withdrawn from the use of topical corticosteroid.
Taniguchi H; Ohki O; Yokozeki H; Katayama I; Tanaka A; Kiyosawa M; Nishioka K
J Dermatol; 1999 Oct; 26(10):658-65. PubMed ID: 10554432
[TBL] [Abstract][Full Text] [Related]
13. Clinical and cost-effectiveness of once-daily versus more frequent use of same potency topical corticosteroids for atopic eczema: a systematic review and economic evaluation.
Green C; Colquitt JL; Kirby J; Davidson P; Payne E
Health Technol Assess; 2004 Nov; 8(47):iii,iv, 1-120. PubMed ID: 15527669
[TBL] [Abstract][Full Text] [Related]
14. Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis.
Wellington K; Jarvis B
Drugs; 2002; 62(5):817-40. PubMed ID: 11929333
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus ointment: utilization patterns in children under age 2 years.
Housman TS; Norton AB; Feldman SR; Fleischer AB; Simpson EL; Hanifin JM; Antaya RJ
Dermatol Online J; 2004 Jul; 10(1):2. PubMed ID: 15347484
[TBL] [Abstract][Full Text] [Related]
17. Optimizing pharmaceutical care for pediatric patients with dermatitis: perspectives of parents and pharmacy staff.
Koster ES; Philbert D; Wagelaar KR; Galle S; Bouvy ML
Int J Clin Pharm; 2019 Jun; 41(3):711-718. PubMed ID: 31020600
[TBL] [Abstract][Full Text] [Related]
18. The treatment of inflammatory facial dermatoses with topical corticosteroids: focus on clocortolone pivalate 0.1% cream.
Kircik LH; Del Rosso JQ
J Drugs Dermatol; 2012 Oct; 11(10):1194-8. PubMed ID: 23134984
[TBL] [Abstract][Full Text] [Related]
19. Topical corticosteroid phobia in patients with atopic eczema.
Charman CR; Morris AD; Williams HC
Br J Dermatol; 2000 May; 142(5):931-6. PubMed ID: 10809850
[TBL] [Abstract][Full Text] [Related]
20. Topical Corticosteroids: Choice and Application.
Stacey SK; McEleney M
Am Fam Physician; 2021 Mar; 103(6):337-343. PubMed ID: 33719380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
